UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003450
Receipt number R000004143
Scientific Title Studies on the additive effects of macrolide antibiotics in the treatment in avian and swine influenza virus infected-patients treated with anti-influenza drugs
Date of disclosure of the study information 2010/04/05
Last modified on 2014/10/05 09:14:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Studies on the additive effects of macrolide antibiotics in the treatment in avian and swine influenza virus infected-patients treated with anti-influenza drugs

Acronym

Studies on the additive effects of macrolide antibiotics in the treatment in avian and swine influenza virus infected-patients treated with anti-influenza drugs

Scientific Title

Studies on the additive effects of macrolide antibiotics in the treatment in avian and swine influenza virus infected-patients treated with anti-influenza drugs

Scientific Title:Acronym

Studies on the additive effects of macrolide antibiotics in the treatment in avian and swine influenza virus infected-patients treated with anti-influenza drugs

Region

Japan


Condition

Condition

Avian and swine influenza virus infection

Classification by specialty

Pneumology Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In order to study the additive effects of macrolide antibiotics in the treatment in avian and swine influenza virus infected-patients treated with anti-influenza drugs

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The presence of nasal discharge and sputum after 5-days of treatment.

Key secondary outcomes

1) The presence of cough 5 days after the treatment.
2) Duration or time of fever 38 degree centigrade or more.
3) Presence of complication with pneumonia.
4) Serum concentrations of inflammatory cytokines (interleukin-1, interleukin-6, TNF-alpha, TGF-beta) after 5-days of treatment.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Treatment with neuraminidase inhibitors plus macrolide antibiotics

Interventions/Control_2

Treatment with neuraminidase inhibitors without macrolide antibiotics

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients diagnosed as type A influenza infection.
2.Patients 16 years old and more, and high school students less than 16 years old.
3.Patients who understand the purpose of this study, and sign agreement forms.

Key exclusion criteria

1. Patients with hypersensitivity to macrolide antibiotics.
2.Patients being treated with agents as follows: pimozide, and agents including ergotamine.
3.Patients judged inappropriate for the study by physicians.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mutsuo Yamaya

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Advanced Preventive Medicine for Infectious Disease

Zip code


Address

2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan

TEL

022-717-7184

Email



Public contact

Name of contact person

1st name
Middle name
Last name Mutsuo Yamaya

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Advanced Preventive Medicine for Infectious Disease

Zip code


Address

2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan

TEL

022-717-7184

Homepage URL


Email

myamaya@med.tohoku.ac.jp


Sponsor or person

Institute

Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院(宮城県)、栗原中央病院(宮城県)、岩手県立磐井病院(岩手県)、岩切病院(宮城県)、東京慈恵会医科大学附属病院(東京都)、済世会宇都宮病院(栃木県)、ひがし内科クリニック(和歌山県)


Other administrative information

Date of disclosure of the study information

2010 Year 04 Month 05 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2010 Year 01 Month 25 Day

Date of IRB


Anticipated trial start date

2010 Year 04 Month 01 Day

Last follow-up date

2013 Year 09 Month 01 Day

Date of closure to data entry

2014 Year 03 Month 01 Day

Date trial data considered complete

2014 Year 05 Month 31 Day

Date analysis concluded

2014 Year 05 Month 31 Day


Other

Other related information



Management information

Registered date

2010 Year 04 Month 05 Day

Last modified on

2014 Year 10 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004143


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name